Abata Therapeutics to Present at Upcoming Investor and Industry Events in June
Abata Therapeutics Announces the Appointment of Leonard Dragone, M.D., Ph.D., as Chief Medical Officer
We Now Know the Enemy: A Conversation with Richard Ransohoff, M.D. Featuring John Maraganore, Ph.D.
Multiple sclerosis: role of meningeal lymphoid aggregates in progression independent of relapse activity
Trends in Immunology
Abata Therapeutics Appoints David Kaufman, M.D., Ph.D., to its Board of Directors